Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

AADI | Aadi Bioscience Inc

Index	RUT	P/E	-	EPS (ttm)	-2.43	Insider Own	30.22%	Shs Outstand	24.44M	Perf Week	-0.38%
Market Cap	127.99M	Forward P/E	-	EPS next Y	-2.92	Insider Trans	-3.29%	Shs Float	17.11M	Perf Month	-23.24%
Income	-61.58M	PEG	-	EPS next Q	-0.72	Inst Own	49.34%	Short Float / Ratio	3.87% / 5.11	Perf Quarter	-28.49%
Sales	21.54M	P/S	5.94	EPS this Y	-2.45%	Inst Trans	13.03%	Short Interest	0.66M	Perf Half Y	-23.80%
Book/sh	5.97	P/B	0.87	EPS next Y	-6.13%	ROA	-44.01%	Target Price	39.75	Perf Year	-58.24%
Cash/sh	5.50	P/C	0.95	EPS next 5Y	-	ROE	-51.28%	52W Range	4.90 - 14.77	Perf YTD	-59.31%
Dividend	-	P/FCF	-	EPS past 5Y	29.51%	ROI	-46.48%	52W High	-64.66%	Beta	1.12
Dividend %	-	Quick Ratio	10.89	Sales past 5Y	213.25%	Gross Margin	91.69%	52W Low	6.53%	ATR	0.34
Employees	79	Current Ratio	11.15	Sales Q/Q	80.45%	Oper. Margin	-310.46%	RSI (14)	41.60	Volatility	5.07% 6.46%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	23.26%	Profit Margin	-285.87%	Rel Volume	0.61	Prev Close	5.24
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Aug 09 BMO	Payout	-	Avg Volume	129.84K	Price	5.22
Recom	1.00	SMA20	-6.99%	SMA50	-9.55%	SMA200	-38.54%	Volume	79,752	Change	-0.38%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-11-22	Initiated	Jefferies	Buy	$45
Oct-01-21	Initiated	Cowen	Outperform
Sep-14-21	Initiated	Ladenburg Thalmann	Buy	$51
Sep-08-21	Initiated	Piper Sandler	Overweight	$45

Sep-20-23 04:30PM	Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (PR Newswire)
Sep-05-23 08:00AM	Aadi Bioscience to Participate at Upcoming Investor Conferences (PR Newswire) -6.31%
Aug-09-23 08:00AM	Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update (PR Newswire) -6.85%
Aug-02-23 08:00AM	Aadi Bioscience to Report Second Quarter 2023 Results and Operational Update (PR Newswire)
May-25-23 05:30PM	Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
08:00AM	Loading…
May-23-23 08:00AM	Aadi Bioscience to Participate in Upcoming Investor Events (PR Newswire)
May-10-23 08:00AM	Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic Trial (PR Newswire) -16.61%
May-03-23 08:00AM	Aadi Bioscience to Report First Quarter 2023 Results and Operational Update (PR Newswire)
Apr-26-23 04:05PM	Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
Apr-14-23 01:00PM	Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
Apr-06-23 04:30PM	Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023 (PR Newswire)
Mar-28-23 08:00AM	Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Corporate Update (PR Newswire) -5.52%
Mar-27-23 08:00AM	Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors (PR Newswire)
Mar-26-23 02:00PM	Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women's Cancer (PR Newswire)
Mar-15-23 08:00AM	Aadi Bioscience to Report Fourth Quarter and Full-Year 2022 Results and Corporate Update (PR Newswire)
08:00AM	Loading…
Mar-03-23 08:00AM	Aadi Bioscience Announces Leadership Transition (PR Newswire) -14.51%
Feb-22-23 08:00AM	Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference (PR Newswire)
Nov-17-22 08:00AM	Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting (PR Newswire)
Nov-09-22 08:00AM	Aadi Bioscience Announces Financial Results for the Third Quarter of 2022 and Provides Corporate Update (PR Newswire)
Nov-08-22 04:00PM	Aadi Bioscience Announces Planned Leadership Transition (PR Newswire)
Nov-03-22 08:00AM	Aadi Bioscience to Present at Upcoming Investor Conferences (PR Newswire)
Oct-27-22 08:00AM	Aadi Bioscience Announces Improved Anti-Tumor Activity of KRAS Inhibitors in Combination with Nab-sirolimus at the 34th EORTC-NCI-AACR Symposium (PR Newswire)
Oct-12-22 08:01AM	Aadi Bioscience Announces Improved Anti-Tumor Activity of KRAS Inhibitors in Combination with Nab-sirolimus at the 34th EORTC-NCI-AACR Symposium (PR Newswire)
08:00AM	Mirati Therapeutics and Aadi Bioscience Partner to Evaluate the Combination of Adagrasib with Nab-sirolimus in Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with a KRAS[G12C] Mutation (PR Newswire)
Sep-22-22 04:01PM	Aadi Bioscience Announces $72.5 Million Private Placement Equity Financing (PR Newswire)
Sep-01-22 08:00AM	Aadi Bioscience Announces Participation in Upcoming September Investor Conferences (PR Newswire)
Aug-10-22 08:00AM	Aadi Bioscience Announces Financial Results for the Second Quarter of 2022 and Provides Corporate Update (PR Newswire)
Aug-04-22 06:21AM	Is Aadi Bioscience, Inc. (NASDAQ:AADI) Popular Amongst Insiders? (Simply Wall St.)
Jul-28-22 08:30AM	Aadi Bioscience to Report Second Quarter 2022 Results and Corporate Update (PR Newswire)
Jun-23-22 08:00AM	Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes (GlobeNewswire) +6.00%
08:00AM	Loading…
Jun-01-22 08:00AM	Aadi Bioscience to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-31-22 08:00AM	Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications (GlobeNewswire)
May-26-22 05:10PM	Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial and Expanded Access Program to be Presented at 2022 ASCO Annual Meeting (GlobeNewswire) +5.11%
May-18-22 07:00AM	Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire) -7.91%
May-12-22 08:32AM	UPDATE -- Aadi Bioscience Reports First Quarter 2022 Financial Results and Provides a Corporate Update (GlobeNewswire) +9.33%
07:00AM	Aadi Bioscience Reports First Quarter 2022 Financial Results and Provides a Corporate Update (GlobeNewswire)
May-09-22 08:00AM	Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders (GlobeNewswire) -10.81%
May-04-22 08:00AM	Aadi Bioscience Announces Unique Permanent J-code Issued for FYARRO from Centers for Medicare and Medicaid Services (GlobeNewswire)
Apr-28-22 05:07PM	Aadi Bioscience to Announce First Quarter 2022 Financial Results on May 12, 2022 (GlobeNewswire)
Apr-18-22 08:00AM	Aadi Bioscience to Participate at the Jefferies Biotech on the Bay Summit (GlobeNewswire) -5.81%
Apr-08-22 01:09PM	Aadi Bioscience Announces Data Presentation on incidence of TSC1 and TSC2 Alterations in Advanced Cancers at the Annual Meeting of the American Association for Cancer Research (AACR) (GlobeNewswire)
Apr-01-22 05:13AM	Top Biotech Stocks for Q2 2022 (Investopedia)
Mar-31-22 02:45PM	Aadi Bioscience Announces First Patient Dosed in its PRECISION 1 Phase 2 Registrational Trial of nab-Sirolimus in Patients with Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 and TSC2 Genes (GlobeNewswire)
Mar-17-22 07:00AM	Aadi Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire) +8.40%
Mar-01-22 07:00AM	Aadi Bioscience to Participate in Panel Discussion on Tumor-Agnostic Development at Cowens 42nd Annual Health Care Conference (GlobeNewswire)
Feb-25-22 04:41AM	Here's What Aadi Bioscience, Inc.'s (NASDAQ:AADI) Shareholder Ownership Structure Looks Like (Simply Wall St.)
Feb-23-22 07:00AM	Aadi Bioscience Announces U.S. Commercial Launch and Availability of FYARRO for the Treatment of Adult Patients with Locally Advanced Unresectable or Metastatic Malignant PEComa (GlobeNewswire)
Jan-04-22 04:30PM	Aadi Bioscience to Present at 2022 H.C. Wainwright BioConnect Virtual Conference (GlobeNewswire)
Dec-28-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-23-21 12:38PM	Rtw Investments, Lp Buys Thermo Fisher Scientific Inc, Penumbra Inc, Tenaya Therapeutics Inc, ... (GuruFocus.com)
Dec-21-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-16-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-08-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Nov-27-21 06:01AM	Companies Like Aadi Bioscience (NASDAQ:AADI) Are In A Position To Invest In Growth (Simply Wall St.)
06:01AM	Some Analysts Just Cut Their Aadi Bioscience, Inc. (NASDAQ:AADI) Estimates (Simply Wall St.)
Nov-23-21 04:22PM	Aadi Bioscience Pops And Then Tumbles After Snagging Its First FDA Approval (Investor's Business Daily)
06:00AM	Aadi Bioscience Announces FDA Approval of its First Product FYARRO for Patients with Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa) (GlobeNewswire)
Nov-15-21 08:00AM	UPDATE Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) (GlobeNewswire) +7.31%
Nov-13-21 01:35PM	Aadi Bioscience Presents Two Abstracts on FYARRO (nab-Sirolimus) at the Annual Meeting of the Connective Tissue Oncology Society (CTOS) (GlobeNewswire)
Nov-10-21 07:00AM	Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire) -16.93%
Nov-09-21 08:00AM	Aadi Bioscience to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-01-21 04:05PM	Aadi Bioscience Appoints Scott Giacobello as Chief Financial Officer (GlobeNewswire)
Oct-25-21 08:00AM	Aadi Bioscience Appoints Loretta Itri as Chief Medical Officer (GlobeNewswire)
Oct-22-21 08:00AM	Aadi Bioscience Announces Publication of its Phase 2 Registrational (AMPECT) Trial of nab-Sirolimus in Patients with Malignant Perivascular Epithelioid Cell Tumors in the Journal of Clinical Oncology (GlobeNewswire)
Oct-19-21 05:22PM	Aadi Bioscience to Participate in H.C. Wainwrights 2nd Annual Precision Oncology Conference 2021 (GlobeNewswire)
Oct-06-21 08:00AM	Aadi Bioscience to Present New Preclinical Data on nab-Sirolimus (ABI-009) at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Sep-20-21 08:30AM	Aadi Bioscience Appoints Brendan Delaney as Chief Operating Officer (GlobeNewswire)
Sep-13-21 08:00AM	Aadi Bioscience Appoints Emma Reeve to its Board of Directors (GlobeNewswire)

Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai on November 2007 and is headquartered in Los Angeles, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Desai Neil	Executive Chairman	Sep 06	Sale	5.29	7,111	37,637	1,663,543	Sep 06 07:05 PM
Desai Neil	Executive Chairman	Sep 05	Sale	5.63	21,000	118,316	1,670,654	Sep 06 07:05 PM
Desai Neil	Executive Chairman	Sep 01	Sale	5.97	13,889	82,873	1,691,654	Sep 06 07:05 PM
Desai Neil	Executive Chairman	Aug 02	Sale	5.20	19,290	100,250	1,705,543	Aug 03 04:22 PM
Desai Neil	Executive Chairman	Aug 01	Sale	5.22	22,710	118,523	1,724,833	Aug 03 04:22 PM
Desai Neil	Executive Chairman	Jul 06	Sale	6.27	15,829	99,273	1,747,543	Jul 06 07:36 PM
Desai Neil	Executive Chairman	Jul 05	Sale	6.55	16,171	105,873	1,763,372	Jul 06 07:36 PM
Desai Neil	Executive Chairman	Jul 03	Sale	6.64	10,000	66,446	1,779,543	Jul 06 07:36 PM
Desai Neil	Executive Chairman	Jun 06	Sale	8.19	7,260	59,453	1,789,543	Jun 06 08:11 PM
Desai Neil	Executive Chairman	Jun 05	Sale	8.11	17,315	140,418	1,796,803	Jun 05 07:01 PM
Desai Neil	Executive Chairman	Jun 02	Sale	7.99	12,443	99,421	1,814,118	Jun 05 07:01 PM
Desai Neil	Executive Chairman	Jun 01	Sale	7.92	4,982	39,468	1,826,561	Jun 05 07:01 PM
Desai Neil	Executive Chairman	May 04	Sale	7.57	2,305	17,445	1,831,543	May 05 04:16 PM
Desai Neil	Executive Chairman	May 03	Sale	7.68	7,695	59,073	1,833,848	May 03 06:55 PM
Desai Neil	Executive Chairman	May 02	Sale	7.48	7,521	56,225	1,841,543	May 03 06:55 PM
Desai Neil	Executive Chairman	May 01	Sale	7.80	24,479	190,895	1,849,064	May 03 06:55 PM
Desai Neil	Executive Chairman	Apr 06	Sale	7.09	12,212	86,616	1,873,543	Apr 06 08:45 PM
Desai Neil	Executive Chairman	Apr 05	Sale	7.24	7,336	53,076	1,885,755	Apr 05 07:32 PM
Desai Neil	Executive Chairman	Apr 04	Sale	7.30	12,869	93,981	1,893,091	Apr 05 07:32 PM
Desai Neil	Executive Chairman	Apr 03	Sale	7.45	9,583	71,355	1,905,960	Apr 05 07:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AADI | Aadi Bioscience Inc

Upgrade your FINVIZ experience